Propel exits herbal health product company
The Australian private equity firm has good news for investors as it raises its third fund booking a 2.5x cash return on its investment in MediHerb.
4 January 2013•1 min read
The Australian private equity firm has good news for investors as it raises its third fund booking a 2.5x cash return on its investment in MediHerb.
